Reckitt Benckiser Pharmaceuticals Inc.
Morris Corporate Center IV
399 Interpace Parkway<br>P.O. Box 225
Parsippany
New Jersey
07054-0225
United States
Tel: 973-404-2600
Fax: 973-404-5700
Website: http://www.reckittbenckiser.com/
22 articles about Reckitt Benckiser Pharmaceuticals Inc.
-
RB announces $25 million investment in a new Reckitt Global Hygiene Institute to strengthen scientific evidence and achieve behavior change
7/16/2020
RB announces the launch of a global initiative to generate high-quality scientific research-based evidence to inform public health recommendations and promote behaviors that improve global hygiene.
-
RB Brings Digital R&D Advances to Popular Consumer Products Through Collaboration with Eagle Genomics
3/19/2020
Global health and hygiene company RB, maker of Lysol, Air Wick, Mucinex, Enfamil and more, announced a collaboration with life sciences knowledge discovery platform company Eagle Genomics.
-
While the biopharma industry awaits news of an acquisition of Shire by Takeda Pharmaceuticals, it’s a good time to take a look back at the bigger deals so far this year.
-
Pfizer’s First Quarter Marked by Strong Pipeline, Jump in Profit, but Lower Revenue than Expected
5/1/2018
Overall, Pfizer posted a good first quarter, with sales slightly higher and a 14 percent increase in profits due to lower restructuring costs and a significantly lower tax rate. However, revenue was below Wall Street expectations. -
Sanofi has agreed to sell its generics division, Zentiva, to Advent International. The deal is expected to wrap by the end of this year.
-
Mylan Rumored to be in Discussions to Buy Merck KGaA’s Consumer Health Business, but Mylan Denies It
4/13/2018
Mylan is reportedly in top-level talks with Germany’s Merck KGaA to buy its consumer health business. However, Mylan has denied it. -
GlaxoSmithKline has decided not to make a play for Pfizer's consumer health business. The decision came one day after another potential suitor walked away from a potential deal.
-
Companies including Sanofi, J&J, Nestle have dropped out.
-
Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment Of Chief Financial Officer
11/4/2014
-
Reckitt Benckiser Pharmaceuticals Inc. Announces Plans To Rebrand Under Indivior PLC Following Demerger
10/21/2014
-
Facebook And Reckitt Benckiser Pharmaceuticals Inc. Partner On Innovative Global Approach To Effectively Reach Consumers In Their Digital Lives
8/4/2014
-
AntiOp Partners With Reckitt Benckiser Pharmaceuticals Inc. To Develop Nasally Administered Treatment For Opioid Overdose
5/21/2014
-
Reckitt Benckiser Pharmaceuticals Inc. Enters Into Agreement To Develop And Market First Naloxone Nasal Treatment For Opioid Overdose
5/19/2014
-
Reckitt Benckiser Pharmaceuticals Inc. Slides As Its Drugs Fail To Take Effect
12/9/2013
-
Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds
12/9/2013
-
Reckitt Benckiser Pharmaceuticals Inc. Relase: Michael "The Situation" Sorrentino Partners With Community Ambassadors to Show the Reality of Opioid Prescription Painkiller Addiction and Motivate Americans Battling the Disease to "Reset Reality"
9/10/2013
-
Reckitt Benckiser Pharmaceuticals Inc. Disappointed Over FDA Denial
2/25/2013
-
Reckitt Benckiser Pharmaceuticals Inc. Buys Golong Medicine of Anhui, a TCM Maker
2/25/2013
-
FDA Grants Approval for Reckitt Benckiser Pharmaceuticals Inc.'s Suboxone Sublingual Film
8/20/2012
-
Reckitt Benckiser Pharmaceuticals Inc. Release: New Report Puts Spotlight on Epidemic of Painkiller Abuse and Need for Patient Education and Resources
11/10/2011